JPRN-UMIN000016856
Completed
N/A
Evaluation of the clinical efficacy of flutiform®(fluticasone propionate /formoterol fumarate) on severe persistent bronchial asthma - Evaluation of the clinical efficacy of flutiform®(fluticasone propionate /formoterol fumarate) on severe persistent bronchial asthma
ConditionsBronchial asthma
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Bronchial asthma
- Sponsor
- Dokkyo Medical University Hospital
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Patients with COPD (2\)Patients who take SABA other than treatment of exacerbations (3\)Patients who had a history of adverse reaction to ICS or LABA (4\)Patients who took flutiform \® within four weeks (5\)Patients with severe cardiac, hepatic, renal, pulmonary, or hematologic disease (6\)Current malignancy (7\)Smoking within past 1 year (8\)Those who are pregnant, under\-lactation, or desire pregnancy (9\)Unsuitability as determined by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Flutiform® Compared With Seretide® in the Treatment of COPDChronic Obstructive Pulmonary DiseaseNCT02195375Mundipharma Research Limited923
Completed
Phase 3
Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible AsthmaAsthmaNCT01099722Mundipharma Research Limited261
Active, Not Recruiting
Phase 3
Evaluation of the efficiency of photobiomodulation in the prevention of oral mucositis? in chemotherapy-treated cancer patientsPrevention of oral mucositis? in chemotherapy-treated cancer patientsOral HealthISRCTN70634383Damascus University45
Active, Not Recruiting
N/A
Clinical study on the efficacy of flutamide for androgen dependent dilated cardiomyopathyJPRN-jRCTs051180123Onoue Kenji2
Active, Not Recruiting
N/A
12 week Chronic Obstructive Pulmonary Disease (COPD)studysubjects with Chronic Obstructive Pulmonary Disease (COPD)MedDRA version: 14.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-024435-16-DEGlaxoSmithKline Research & Development Ltd248